// App-Quantinova.ai

2177 : Concomitant Occurrence of Polyclonal Hematopoiesis and Cell-Autonomous Megakaryopoiesis in Triple-Negative Essential Thrombocythemia

Researchers

Presenter

  • Tadaaki Inano

Principal Investigators

  • Marito Araki

  • Soji Morishita

  • Misa Imai

  • Yoshihiko Kihara

  • Maho Okuda

  • Masafumi Ito

  • Satoshi Osaga

  • Yinjie Yang

  • Yoko Edahiro

  • Tomonori Ochiai

  • Kyohei Misawa

  • Yasutaka Fukuda

  • Akimichi Ohsaka

  • Norio Komatsu

Medical Centers

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

  • Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan

  • Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

  • Research Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, TOkyo, Japan

  • Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Calreticulin

  • Interleukin 6

  • Signal transducer and activator of transcription 5

Drug/Treatment

  • ILS-969

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved